Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Cognitive Dysfunction in Elderly Patients
NCT02134093Phase 4Unknown
- Sponsor
- Tangdu Hospital
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) (3 arms), sponsored by Tangdu Hospital. Primary endpoints: The change in memory, Cognitive function and 1 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT02134093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02134093.